PubMed:33097184
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 34-46 | Body_part | denotes | gangliosides | http://purl.org/sig/ont/fma/fma82816 |
T2 | 275-282 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 472-483 | Body_part | denotes | ganglioside | http://purl.org/sig/ont/fma/fma82816 |
T4 | 531-536 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T5 | 550-565 | Body_part | denotes | plasma membrane | http://purl.org/sig/ont/fma/fma63841 |
T6 | 603-610 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T7 | 622-627 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T8 | 687-699 | Body_part | denotes | gangliosides | http://purl.org/sig/ont/fma/fma82816 |
T9 | 966-974 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T10 | 1045-1056 | Body_part | denotes | ganglioside | http://purl.org/sig/ont/fma/fma82816 |
T11 | 1108-1113 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T12 | 1129-1137 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T13 | 1156-1163 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T14 | 1192-1200 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T15 | 1307-1318 | Body_part | denotes | ganglioside | http://purl.org/sig/ont/fma/fma82816 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1216-1219 | Body_part | denotes | tip | http://purl.obolibrary.org/obo/UBERON_2001840 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 105-113 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 130-140 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T3 | 141-160 | Disease | denotes | respiratory disease | http://purl.obolibrary.org/obo/MONDO_0005087 |
T4 | 188-196 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 223-232 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 451-454 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T8 | 741-744 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T10 | 785-788 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T12 | 792-800 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 1011-1014 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T15 | 1227-1230 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T17 | 1242-1250 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T18 | 1337-1345 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 168-169 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 200-201 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T3 | 261-266 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T4 | 341-342 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 465-466 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 514-519 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T7 | 550-556 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T8 | 557-565 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T9 | 806-807 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T10 | 870-871 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T11 | 951-952 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T12 | 1099-1104 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 34-46 | Chemical | denotes | gangliosides | http://purl.obolibrary.org/obo/CHEBI_28892 |
T2 | 275-282 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 472-483 | Chemical | denotes | ganglioside | http://purl.obolibrary.org/obo/CHEBI_28892 |
T4 | 531-536 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T5 | 603-610 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T6 | 622-627 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T7 | 652-670 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T8 | 687-699 | Chemical | denotes | gangliosides | http://purl.obolibrary.org/obo/CHEBI_28892 |
T9 | 708-720 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T10 | 1024-1031 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
T11 | 1045-1056 | Chemical | denotes | ganglioside | http://purl.obolibrary.org/obo/CHEBI_28892 |
T12 | 1108-1113 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T13 | 1156-1163 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T14 | 1307-1318 | Chemical | denotes | ganglioside | http://purl.obolibrary.org/obo/CHEBI_28892 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 11-22 | Species | denotes | coronavirus | Tax:11118 |
4 | 34-46 | Chemical | denotes | gangliosides | MESH:D005732 |
5 | 105-113 | Disease | denotes | COVID-19 | MESH:C000657245 |
25 | 115-123 | Disease | denotes | Covid-19 | MESH:C000657245 |
26 | 141-160 | Disease | denotes | respiratory disease | MESH:D012140 |
27 | 170-181 | Species | denotes | coronavirus | Tax:11118 |
28 | 188-198 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
29 | 223-232 | Disease | denotes | infection | MESH:D007239 |
30 | 472-483 | Chemical | denotes | ganglioside | MESH:D005732 |
31 | 531-536 | Chemical | denotes | lipid | MESH:D008055 |
32 | 622-627 | Chemical | denotes | lipid | MESH:D008055 |
33 | 652-670 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
34 | 687-699 | Chemical | denotes | gangliosides | MESH:D005732 |
35 | 708-720 | Chemical | denotes | azithromycin | MESH:D017963 |
36 | 792-802 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
37 | 929-937 | Disease | denotes | Covid-19 | MESH:C000657245 |
38 | 938-946 | Species | denotes | patients | Tax:9606 |
39 | 1045-1056 | Chemical | denotes | ganglioside | MESH:D005732 |
40 | 1108-1113 | Chemical | denotes | lipid | MESH:D008055 |
41 | 1242-1252 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
42 | 1307-1318 | Chemical | denotes | ganglioside | MESH:D005732 |
43 | 1337-1347 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-114 | Sentence | denotes | Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19. |
T2 | 115-199 | Sentence | denotes | Covid-19 is an infectious respiratory disease due to a coronavirus named SARS-CoV-2. |
T3 | 200-314 | Sentence | denotes | A critical step of the infection cycle is the binding of the virus spike S protein to the cellular ACE-2 receptor. |
T4 | 315-600 | Sentence | denotes | This interaction involves a receptor binding domain (RBD) located at the center of the S trimer, whereas the lateral N-terminal domain (NTD) displays a flat ganglioside binding site that enables the virus to bind to lipid rafts of the plasma membrane, where the ACE-2 receptor resides. |
T5 | 601-745 | Sentence | denotes | S protein binding to lipid rafts can be blocked by hydroxychloroquine, which binds to gangliosides, and by azithromycin, which binds to the NTD. |
T6 | 746-1015 | Sentence | denotes | Based on these data, we identified the NTD of SARS-CoV-2 as a promising target for both therapeutic and vaccine strategies, a notion later supported by the discovery, in convalescent Covid-19 patients, of a neutralizing antibody (4A8) that selectively binds to the NTD. |
T7 | 1016-1164 | Sentence | denotes | The 4A8 epitope overlaps the ganglioside binding domain, denying any access of the virus to lipid rafts when the antibody is bound to the S protein. |
T8 | 1165-1268 | Sentence | denotes | Thus, our data explain why antibody binding to the tip of the NTD results in SARS-CoV-2 neutralization. |
T9 | 1269-1480 | Sentence | denotes | The high level of conservation of the ganglioside binding domain of SARS-CoV-2 (100% identity in 584 of 600 isolates analyzed worldwide) offers unique opportunities for innovative vaccine/therapeutic strategies. |